Amgen Inc. (AMGN) announced after the close Thursday that the U.S. District ... Amgen gapped open sharply higher Friday, but pared its gains over the course of the session. The stock finished up by 3.80 at $156.78 on above average …
Biogen, Novartis (NYSE:NVS) , Eisai, AstraZeneca and Amgen (NASDAQ:AMGN) are presently working on Alzheimer ... list of today’s Zacks #1 Rank (Strong Buy) stocks here. More Stock News: This Is Bigger than the iPhone! It could …
Amgen has a market capitalization of more than $90 billion and a dividend yield near 2.0 percent. Of the 27 analysts who follow the stock that were surveyed by Thomson/First Call, 13 recommend buying shares, and the rest rate it at Hold. …
Traders faced front and center as continued turmoil in Italy weighed on major stock indexes as details of France’s new …
We expect shares to trade off on the elevated expenses though the stock market was arguably prepared for it with ... and 3.8% dividend yield. Amgen (AMGN): Reiterate outperform rating. Remain buyers after a solid fourth quarter beat and …
Amgen shares were down all Wednesday afternoon, slipping 1.61% since the morning. The stock is up 10% YTD. Amgen (AMGN) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars. Be sure to visit …
Hong Kong Exchanges and Clearing Ltd. (HKEX) has formed a panel of 13 experts to assist review of applications from companies seeking to list on the exchange's new prerevenue biotech chapter. The advisory panel's members, who will …
The stock increased 0.37% or $0.21 during the last trading session ... decreased its stake in Amgen Inc …
AMGN Earnings in Focus The company reported earnings of $2.30 ... Gilead's shares dropped 4% in extending market trading on account of the Solvadi sales miss. Though the stock might trade lower for some more days, it nonetheless …
On Sunday, the world's largest independent biotechnology company, Amgen Inc. (Nasdaq: AMGN), bought Onyx Pharmaceuticals Inc. (Nasdaq: ONXX) in a $10.4 billion dollar deal – making it the fifth-largest biotech deal in history …